evaluated a 2-week treatment with different doses of larazotide, ranging from 0.5 to 8 mg t.i.d., with daily gluten challenge in 86 celiac disease patients on a gluten-free diet (97)
It's important to note that GLP-1 receptor agonists are not indicated for type 1 diabetes or for the treatment of diabetic ketoacidosis
Consider: Escalating to next dose tier Evaluating adherence and lifestyle factors Checking for medication-interfering conditions (hypothyroidism, PCOS, sleep apnea) Discussing alternative treatments Dose-response comparison table: Wegovy vs Zepbound Data from STEP 1 (Wilding et al., NEJM 2021) and SURMOUNT-1 (Jastreboff et al., NEJM 2022)
Posso-Osorio I, Vargas-Potes CJ, Meja M, et al
Gentle skincare routine: Use products that are suitable for your skin type, and regularly cleanse, exfoliate, and moisturize to remove impurities and keep the skin smooth and healthy